Anzeige
Mehr »
Montag, 27.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41083 | ISIN: US68620A3023 | Ticker-Symbol: 4OR
Lang & Schwarz
25.10.25 | 09:00
1,220 Euro
-100,00 % -1,220
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOSIM LABS INC Chart 1 Jahr
5-Tage-Chart
VIVOSIM LABS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,2101,23025.10.

Aktuelle News zur VIVOSIM LABS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.08.VivoSim Labs, INC. - S-8, Securities to be offered to employees in employee benefit plans21
14.08.VivoSim Labs names Tony Lialin as chief commercial officer9
14.08.VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer495SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing...
► Artikel lesen
VIVOSIM LABS Aktie jetzt für 0€ handeln
14.08.VivoSim Labs, INC. - 8-K, Current Report3
12.08.VivoSim Labs, INC. - 10-Q, Quarterly Report9
29.07.VivoSim Labs, INC. - 10-K/A, Annual Report8
05.06.VivoSim Labs, INC. - 10-K, Annual Report29
06.05.VivoSim Labs, INC. - 8-K, Current Report27
24.04.VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market645SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development....
► Artikel lesen
02.04.Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements441SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
27.03.Organovo, Inc.: Organovo Provides Business Update262SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
25.03.Organovo Sells FXR Program To Eli Lilly2.388INDIANAPOLIS (dpa-AFX) - Organovo Holdings Tuesday has completed the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY).The transaction, finalized on March...
► Artikel lesen
25.03.Organovo, Inc.: Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company606SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
21.03.XFRA 4OR: AUSSETZUNG/SUSPENSION503DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILORGANOVO HLDGS DL-...
► Artikel lesen
21.03.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 21.03.2025612The following instruments on XETRA do have their first trading 21.03.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 21.03.2025 Aktien 1 US04351N1063 Ascend Wellness Holdings...
► Artikel lesen
20.03.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.03.2025608The following instruments on Boerse Frankfurt do have their last trading day on 20.03.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.03.2025.ISIN NameCA22675G1028 CRITICAL...
► Artikel lesen
20.03.XFRA ISIN CHANGE532Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA22675G1028 Critical Reagents Processing Corp. 20.03.2025 CA22675G2018 Critical Reagents Processing Corp. 21.03.2025 Tausch...
► Artikel lesen
19.03.Organovo, Inc.: Organovo Announces Reverse Stock Split380SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel...
► Artikel lesen
25.02.Organovo, Inc.: Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company892SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
06.01.Organovo, Inc.: Organovo Announces Appointment of Norman Staskey as Chief Financial Officer377SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1